PL
VOR icon

Parkwood LLC’s Vor Biopharma VOR Stock Holding History

Parkwood LLC’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,697
Closed -$228K – 169
2023
Q2 		$228K Buy
3,697
+2,610
+240% +$238K 0.04% 119
2023
Q1 		$117K Buy
+1,087
New +$120K 0.02% 138
2022
Q1 		– Sell
-1,969
Closed -$458K – 150
2021
Q4 		$458K Sell
1,969
-498
-20% -$144K 0.08% 97
2021
Q3 		$774K Sell
2,467
-70
-3% -$20.8K 0.09% 95
2021
Q2 		$946K Buy
+2,537
New +$1.25M 0.11% 99

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Parkwood LLC's VOR Position: Q3 2023 in Review

Parkwood LLC sold out of Vor Biopharma (VOR) in Q3 2023, closing a stake of 3,697 shares — an estimated $228K sold.

Parkwood LLC first reported a position in VOR in Q2 2021 and held it in 5 quarters. The position peaked at $946K in Q2 2021. 59 funds tracked by Wall St. Rank hold VOR as of Q3 2023.

  • Parkwood LLC reported no remaining Vor Biopharma position as of Q3 2023 after selling out during the quarter.
  • Parkwood LLC sold 3,697 Vor Biopharma shares in Q3 2023, an estimated $228K.
  • Parkwood LLC first reported a position in Vor Biopharma in Q2 2021 and held it in 5 quarters.
  • Parkwood LLC's Vor Biopharma position peaked at $946K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2023.

Based on Parkwood LLC's 13F filing for Q3 2023, filed 14 Nov 2023.